New strategies in the management of valvular heart disease: A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease

Gudrun Lamm

doi:10.1007/s00508-021-01879-y

New strategies in the management of valvular heart disease: A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease

Gudrun Lamm

Division of Internal Medicine 3 (University Hospital St. Pölten)

Research output: Journal article (peer-reviewed) › Review article

2 Citations (Scopus)

Abstract

The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.

Original language	English
Pages (from-to)	786-789
Number of pages	4
Journal	Wiener Klinische Wochenschrift
Volume	133
Issue number	15-16
DOIs	https://doi.org/10.1007/s00508-021-01879-y
Publication status	Published - Aug 2021

Keywords

American Heart Association
Cardiology
Heart Valve Diseases/surgery
Humans
Transcatheter Aortic Valve Replacement
United States

Access to Document

10.1007/s00508-021-01879-y

Cite this

@article{61963b6df0dd419882a7acfa1e2eb81f,

title = "New strategies in the management of valvular heart disease: A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease",

abstract = "The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.",

keywords = "American Heart Association, Cardiology, Heart Valve Diseases/surgery, Humans, Transcatheter Aortic Valve Replacement, United States",

author = "Gudrun Lamm",

note = "Publisher Copyright: {\textcopyright} 2021, Springer-Verlag GmbH Austria, part of Springer Nature.",

year = "2021",

month = aug,

doi = "10.1007/s00508-021-01879-y",

language = "English",

volume = "133",

pages = "786--789",

journal = "Wiener Klinische Wochenschrift",

issn = "0043-5325",

publisher = "Springer-Verlag Wien",

number = "15-16",

}

TY - JOUR

T1 - New strategies in the management of valvular heart disease

T2 - A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease

AU - Lamm, Gudrun

PY - 2021/8

Y1 - 2021/8

N2 - The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.

AB - The advent of transcatheter procedures for treatment of valvular heart disease has accelerated the pace of research in the diagnosis and treatment of heart valve disease. Rapid accumulation of novel knowledge in the field necessitates timely revisions of clinical guidelines. This paper comments on some important and novel issues addressed in the recently published American College of Cardiology/American Heart Association (ACC/AHA) guidelines.

KW - American Heart Association

KW - Cardiology

KW - Heart Valve Diseases/surgery

KW - Humans

KW - Transcatheter Aortic Valve Replacement

KW - United States

UR - http://www.scopus.com/inward/record.url?scp=85103261106&partnerID=8YFLogxK

U2 - 10.1007/s00508-021-01879-y

DO - 10.1007/s00508-021-01879-y

M3 - Review article

C2 - 34057577

SN - 0043-5325

VL - 133

SP - 786

EP - 789

JO - Wiener Klinische Wochenschrift

JF - Wiener Klinische Wochenschrift

IS - 15-16

ER -

New strategies in the management of valvular heart disease: A critical appraisal on the top 10 messages of the 2020 ACC/AHA guidelines for the management of patients with valvular heart disease

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this